Exparel Versus Bupivacaine in Post-operative Pain Control Following Bilateral Third Molar Extractions: a Single-blind Randomized Clinical Trial
Latest Information Update: 20 Feb 2025
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- 13 Feb 2025 Planned End Date changed from 31 Dec 2024 to 31 Jul 2025.
- 13 Feb 2025 Planned primary completion date changed from 30 Nov 2024 to 30 May 2025.
- 02 Sep 2024 Status changed from not yet recruiting to recruiting.